Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Open in API
Filings indexed 859 across all filing types
Latest filing 2014-09-02 Interim / Quarterly Rep…
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, uniQure N.V., with the SEC. It includes unaudited financial statements for the three and six month periods ended June 30, 2014, and a press release announcing these results. Form 6-K is used for interim or quarterly reports by foreign private issuers. The document length is 2418 characters, which is relatively short but contains actual financial statements for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2014-09-02 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes press releases about a product launch update and an acquisition. The document is relatively short (2562 characters) and primarily serves as a regulatory filing to disclose material information. It does not contain comprehensive financial statements or detailed management discussion. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2014-08-12 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 registration statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes detailed information about share incentive plans, option plans, and registration fees. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration under the Securities Act of 1933. The document is lengthy (15,000 characters) and contains the full registration statement text, not just an announcement or certification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2014-08-06 English
6-K
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, uniQure N.V., with the SEC. It includes a press release dated July 1, 2014, announcing an additional $10 million venture debt loan from Hercules Technology Growth Capital, Inc. The document length is 2157 characters, which is relatively short and primarily contains an announcement of a financing event rather than detailed financial data or a full report. The content focuses on a capital raising update (venture debt loan), which fits the Capital/Financing Update category. It is not an annual or interim report, audit report, or earnings release. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2014-07-02 English
6-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, uniQure N.V. It reports the voting results of the 2014 Annual General Meeting (AGM) of Shareholders held on June 11, 2014. The content focuses exclusively on the outcomes of shareholder votes on various agenda items such as adoption of the annual report, discharge of liability for the Management and Supervisory Boards, appointment of a new Supervisory Director, reappointment of the auditor, and authorizations related to share issuance and repurchase. There is no detailed financial data or management discussion, only the official voting results. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)" which covers official results from shareholder votes at any general meeting. The document length is 4507 characters, which is sufficient to contain detailed voting results but not a full report. Therefore, the correct classification is DVA with high confidence.
2014-06-16 English
6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, uniQure N.V., with the SEC. It includes unaudited financial statements for the three months ended March 31, 2014, and a press release announcing the company's results for that period. Form 6-K is used by foreign private issuers to report material information between annual reports. The document length is 2344 characters, which is relatively short and includes references to exhibits with financial statements and a press release. This matches the characteristics of an Interim / Quarterly Report (IR) because it contains actual financial data for a period shorter than a full fiscal year (quarterly results). Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2014-06-06 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.